TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Swedish Orphan Biovitrum AB (publ)
Closing information (x1000 DKK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
14,859,454
|
12,556,103
|
11,291,623 |
| Financial expenses |
780,486
|
332,112
|
330,118 |
| Earnings before taxes |
1,984,126
|
2,219,203
|
2,395,898 |
| EBITDA |
4,858,893
|
4,067,536
|
4,168,644 |
| Total assets |
49,722,047
|
35,079,572
|
35,382,941 |
| Current assets |
8,510,787
|
7,491,563
|
6,382,759 |
| Current liabilities |
12,825,624
|
9,927,941
|
6,370,398 |
| Equity capital |
22,747,600
|
17,724,887
|
16,871,630 |
| - share capital |
130,305
|
113,600
|
122,885 |
| Employees (average) |
1,772
|
1,556
|
1,559 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
45.7%
|
50.5%
|
47.7% |
| Turnover per employee |
8,386
|
8,069
|
7,243 |
| Profit as a percentage of turnover |
13.4%
|
17.7%
|
21.2% |
| Return on assets (ROA) |
5.6%
|
7.3%
|
7.7% |
| Current ratio |
66.4%
|
75.5%
|
100.2% |
| Return on equity (ROE) |
8.7%
|
12.5%
|
14.2% |
| Change turnover |
2,238,691
|
2,179,109
|
194,871 |
| Change turnover % |
18%
|
21%
|
2% |
| Chg. No. of employees |
216
|
-3
|
50 |
| Chg. No. of employees % |
14%
|
0%
|
3% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.